Vanguard Global Advisers »

Avalo Therapeutics Ord shares owned by Vanguard Global Advisers

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Vanguard Global Advisers from 13F filings

Historical chart of Vanguard Global Advisers investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Vanguard Global Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Vanguard Global Advisers

Quarter filed Position value Share count Share price at filing
2026-03-31 $84k 5.6k 14.93

More positions owned by Vanguard Global Advisers

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Vanguard Specialized Funds Div App Etf (VIG)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
JPMorgan Chase & Co. (JPM)

View all positions for Vanguard Global Advisers

Top funds holding Avalo Therapeutics Ord

BVF
Logos Global Management
Nantahala Capital Management
UBS Group
Affinity Asset Advisors
Point72 Asset Management
Caligan Partners
Millennium Management
Vanguard Group
TCG Crossover Management
Balyasny Asset Management
Vanguard Capital Management
RA Capital Management
Bank of America Corporation
Ikarian Capital

View all funds holding Avalo Therapeutics Ord